hg_60244.1

Basic information about the TSS

---

TSS ID: hg_60244.1 Species: human Chr: chr5		Start: 172834449 End: 172834460 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AB463606 Distance: -36 GeneID: 57222 HGNC/MGI_ID: HGNC:29205 UniProt_ID:

Gene_name: endoplasmic reticulum-golgi intermediate compartment 1 Gene_symbol: ERGIC1 Gene_synonyms: ERGIC-32 ERGIC32 KIAA1181 NET24 Gene_source: HGNC:29205

TATA-Box annotation

---

Distance to TSS:	204
Nearest PromoterID:	NM_001031711
Entrez ID:	57222
Nearest Unigene:	Hs.509163
Nearest Refseq:	NM_020462
Nearest Ensembl:	ENSG00000113719
Gene Name:	endoplasmic reticulum-golgi intermediate compartment 1
Gene Alias:	AMCN|ERGIC-32|ERGIC32|NET24
Gene Description:	endoplasmic reticulum-golgi intermediate compartment 1
Gene Type:	protein-coding
CpG%:	0.12
GC%:	0.756219
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ERGIC1 p2@ERGIC1 p3@ERGIC1
Sample		p1@ERGIC1	p2@ERGIC1	p3@ERGIC1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	5.45	9.16	3.31
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	5.06	11.33	3.84
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	5.98	8.49	4.05
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	5.82	10.19	4.99
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.27	7.20	4.72
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.01	7.75	3.49
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	7.41	10.68	5.01
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.02	5.57	3.88
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	5.13	8.55	4.70
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	3.48	4.06	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	3.23	4.45	4.85
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	3.66	6.50	4.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	33.85	42.39	7.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	33.98	32.63	7.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	37.54	33.81	4.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	30.43	32.95	5.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	36.26	31.45	4.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	29.95	31.21	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	27.72	22.39	7.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	32.65	30.84	5.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	31.41	30.61	5.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	29.35	33.32	7.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	34.90	29.86	6.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	31.30	25.97	7.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	31.47	30.70	6.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	27.85	24.69	5.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.57	22.53	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	32.53	39.37	6.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.81	31.82	4.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	30.04	33.12	5.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	30.35	29.94	6.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	27.35	27.16	4.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	30.81	27.64	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	25.90	21.77	3.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	29.36	29.54	5.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	30.85	34.49	6.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	25.14	31.88	6.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.79	29.62	3.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	27.55	31.06	4.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	26.65	29.05	6.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	25.64	30.35	5.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	18.88	22.25	3.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	25.94	26.99	5.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	25.00	29.72	6.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	25.30	31.32	6.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	23.26	26.06	6.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	25.67	29.27	4.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	19.67	23.84	5.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	26.57	29.92	4.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	25.68	26.89	4.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.52	26.23	5.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	26.46	37.14	6.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	24.13	31.23	4.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.56	31.81	4.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	4.19	9.23	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	10.10	9.64	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	16.53	28.20	3.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.02	30.19	8.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.94	17.29	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	23.27	23.27	9.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	12.90	22.43	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	6.37	7.17	6.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.17	13.59	4.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	23.39	27.94	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	17.39	27.69	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	27.30	34.61	10.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	40.66	43.14	7.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	31.43	44.10	4.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	32.79	34.11	10.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	41.14	44.85	6.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	50.45	60.54	6.11
Adipocyte - breast, donor1	11376-118A8	66.52	32.15	16.47
Adipocyte - breast, donor2	11327-117E4	83.10	40.27	15.88
Adipocyte - omental, donor1	11473-119C6	103.18	46.95	15.27
Adipocyte - omental, donor2	11474-119C7	71.76	51.58	5.98
Adipocyte - omental, donor3	11475-119C8	47.56	47.22	14.40
Adipocyte - perirenal, donor1	11476-119C9	105.91	46.57	16.59
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	20.89	18.69
Adipocyte - subcutaneous, donor2	11336-117F4	122.84	48.78	28.90
Adipocyte - subcutaneous, donor3	11408-118E4	78.55	37.54	19.12
Adipocyte differentiation, day04, donor1	13019-139D4	58.08	51.83	15.25
Adipocyte differentiation, day04, donor2	13022-139D7	26.51	21.88	8.75
Adipocyte differentiation, day04, donor3	13025-139E1	55.75	38.19	13.94
Adipocyte differentiation, day04, donor4	13028-139E4	38.80	34.68	11.17
Adipocyte differentiation, day08, donor1	13020-139D5	48.02	33.14	11.74
Adipocyte differentiation, day08, donor2	13023-139D8	30.66	24.85	8.07
Adipocyte differentiation, day08, donor3	13026-139E2	30.92	13.33	5.87
Adipocyte differentiation, day08, donor4	13029-139E5	36.17	20.03	7.79
Adipocyte differentiation, day12, donor1	13021-139D6	50.32	32.86	16.64
Adipocyte differentiation, day12, donor2	13024-139D9	23.61	19.84	9.29
Adipocyte differentiation, day12, donor3	13027-139E3	29.78	19.31	14.40
Adipocyte differentiation, day12, donor4	13030-139E6	34.41	21.31	15.22
Alveolar Epithelial Cells, donor1	11510-119G7	127.07	82.21	26.30
Alveolar Epithelial Cells, donor2	11590-120G6	82.47	77.81	26.89
Alveolar Epithelial Cells, donor3	11671-122G6	57.50	38.34	16.77
Amniotic Epithelial Cells, donor1	11533-120A3	23.93	43.54	17.63
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	33.47	15.06
Amniotic Epithelial Cells, donor3	11694-123A2	27.32	56.50	22.39
Anulus Pulposus Cell, donor1	11248-116E6	85.13	46.11	16.71
Anulus Pulposus Cell, donor2	11463-119B5	60.00	51.19	23.27
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	38.19	26.51	17.97
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	46.89	35.17	13.89
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	49.23	19.26	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	37.96	44.24	12.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	43.00	30.35	12.65
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	31.68	17.82	9.24
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	37.04	39.31	9.75
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	28.16	42.72	17.96
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	45.13	26.13	13.66
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	30.51	41.43	13.56
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	34.83	35.56	18.14
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	27.58	22.57	8.78
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	43.33	27.18	11.04
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	34.12	32.76	10.92
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	31.36	26.84	11.31
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	35.36	38.58	14.47
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	40.81	43.64	13.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	46.78	24.06	12.30
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	21.46	39.02	10.73
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	37.82	39.31	12.77
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	22.81	26.42	7.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	35.40	14.16
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	42.02	42.71	16.30
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	33.56	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	32.04	35.92	13.59
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	39.84	48.57	12.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	50.88	16.96	14.54
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	35.91	39.90	15.39
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	38.91	41.47	12.40
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	34.84	32.78	12.90
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	40.82	42.23	15.48
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	43.09	45.66	12.54
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	37.81	22.12	11.42
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.98	28.66	13.45
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	40.64	38.84	18.37
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	43.96	27.32	9.50
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	38.14	34.58	16.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	43.30	34.38	14.77
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	40.03	26.69	7.62
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	44.88	41.43	18.56
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	51.02	36.83	11.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	36.54	28.71	11.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	43.46	39.68	23.62
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	46.11	40.69	17.80
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	20.85	11.58
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	35.91	40.14	8.45
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	33.23	33.02	13.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	33.69	28.28	9.02
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	33.53	24.79	16.77
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	37.70	37.24	11.95
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	28.05	22.95	10.20
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	37.63	22.63	8.90
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	47.89	41.91	13.42
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	38.86	22.95	8.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	42.07	36.33	18.16
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	37.25	37.03	12.20
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	32.04	24.41	10.68
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	32.13	31.02	13.85
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	37.34	34.69	11.65
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	31.98	22.17	6.91
Astrocyte - cerebellum, donor1	11500-119F6	36.35	46.42	22.23
Astrocyte - cerebellum, donor2	11580-120F5	37.14	58.02	21.91
Astrocyte - cerebellum, donor3	11661-122F5	23.07	24.12	23.07
Astrocyte - cerebral cortex, donor1	11235-116D2	18.82	27.54	11.50
Astrocyte - cerebral cortex, donor2	11316-117D2	31.22	35.59	13.59
Astrocyte - cerebral cortex, donor3	11392-118C6	32.22	37.74	11.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	34.29	51.26	15.48
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	32.45	51.99	14.16
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	33.80	48.93	14.22
Basophils, donor1	12241-129G9	22.23	18.83	20.40
Basophils, donor2	12242-129H1	19.12	15.51	24.17
Basophils, donor3	12243-129H2	35.72	36.16	34.99
Bronchial Epithelial Cell, donor1	11511-119G8	20.27	29.97	25.44
Bronchial Epithelial Cell, donor2	11591-120G7	9.14	30.63	17.83
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	43.04	28.69
Bronchial Epithelial Cell, donor4	11453-119A4	11.30	16.32	9.41
Bronchial Epithelial Cell, donor5	11457-119A8	15.80	30.36	11.65
Bronchial Epithelial Cell, donor6	11461-119B3	12.67	22.34	14.51
Bronchial Epithelial Cell, donor7	11769-123I5	12.60	27.35	24.47
Burkitt's lymphoma cell line:DAUDI	10422-106C8	34.63	32.46	29.16
Burkitt's lymphoma cell line:RAJI	10476-106I8	15.14	26.78	13.74
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	17.27	27.50	47.97
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	72.39
CD14+ Monocytes, donor1	11224-116B9	46.78	20.29	27.61
CD14+ Monocytes, donor2	11305-117B9	50.67	27.28	31.55
CD14+ Monocytes, donor3	11381-118B4	52.25	29.42	27.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	11.32	16.13	13.02
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	14.40	25.78	20.85
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	9.53	23.34	17.42
CD14+ monocytes - mock treated, donor1	11863-125A9	58.25	27.75	18.65
CD14+ monocytes - mock treated, donor2	11873-125C1	67.89	25.04	19.01
CD14+ monocytes - mock treated, donor3	11883-125D2	89.78	31.03	21.56
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	45.70	18.41	16.74
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	59.62	19.04	16.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	52.07	21.32	18.84
CD14+ monocytes - treated with BCG, donor1	11860-125A6	29.96	17.43	16.45
CD14+ monocytes - treated with BCG, donor2	11870-125B7	36.32	22.97	20.12
CD14+ monocytes - treated with BCG, donor3	11880-125C8	28.73	15.23	19.59
CD14+ monocytes - treated with Candida, donor1	11868-125B5	38.16	16.62	13.58
CD14+ monocytes - treated with Candida, donor2	11878-125C6	47.52	22.18	15.31
CD14+ monocytes - treated with Candida, donor3	11888-125D7	47.70	18.86	9.98
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	64.71	25.58	18.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	74.83	25.14	18.76
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	63.29	19.15	13.53
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	71.15	27.45	16.47
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	51.80	18.10	18.55
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	64.60	22.26	20.08
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	31.20	19.10	16.68
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	46.23	24.95	23.20
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	42.50	24.41	23.15
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	42.99	17.09	17.09
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	43.68	22.90	16.20
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	65.37	23.25	18.43
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	29.99	20.05	17.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	26.39	21.93	20.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	36.86	19.61	18.32
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	39.31	23.75	15.97
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	27.58	11.13	12.98
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	37.58	12.99	8.82
CD14+CD16+ Monocytes, donor1	11789-124B7	30.51	18.74	18.53
CD14+CD16+ Monocytes, donor2	11801-124D1	45.51	28.64	18.48
CD14+CD16+ Monocytes, donor3	11912-125G4	29.46	17.98	11.26
CD14+CD16- Monocytes, donor1	11788-124B6	56.06	28.19	23.20
CD14+CD16- Monocytes, donor2	11799-124C8	35.28	22.35	19.21
CD14+CD16- Monocytes, donor3	11910-125G2	42.14	31.22	32.11
CD14-CD16+ Monocytes, donor1	11790-124B8	49.50	27.56	19.14
CD14-CD16+ Monocytes, donor2	11800-124C9	44.57	25.91	19.54
CD14-CD16+ Monocytes, donor3	11911-125G3	50.11	26.53	20.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	26.42	22.36
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	14.24	25.76	37.97
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	9.32	15.53	39.35
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	8.53	19.19	35.71
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	15.01	31.63	38.06
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	12.63	21.06	25.97
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	13.33	21.96	36.86
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	10.55	21.09	31.64
CD19+ B Cells, donor1	11544-120B5	18.08	45.20	50.96
CD19+ B Cells, donor2	11624-122B4	31.19	45.70	58.76
CD19+ B Cells, donor3	11705-123B4	30.29	52.50	59.06
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1.21	4.04	7.68
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1.60	1.20	6.39
CD34+ Progenitors, donor1	11545-120B6	10.04	21.09	36.15
CD34+ Progenitors, donor2	11625-122B5	12.36	10.67	35.39
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	19.54	34.95	42.84
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.45	29.09	27.73
CD4+ T Cells, donor1	11225-116C1	1.43	5.00	51.06
CD4+ T Cells, donor2	11306-117C1	1.22	4.90	42.87
CD4+ T Cells, donor3	11382-118B5	1.83	4.57	45.14
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1.79	5.10	31.39
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	1.57	8.09	30.99
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	2.30	8.05	33.92
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.95	3.32	47.88
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.70	5.62	60.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	3.30	42.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.72	3.90	27.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.51	2.71	29.32
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.97	4.51	25.15
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.90	4.03	29.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1.75	3.84	38.78
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1.32	6.16	36.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	6.75	17.29
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	1.66	6.03	27.01
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	2.34	2.67	17.37
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1.63	3.26	50.31
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1.07	3.22	57.88
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	5.38	57.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.56	3.52	27.44
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.43	4.77	29.24
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.21	1.47	24.80
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	3.54	36.91
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1.30	3.03	37.26
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1.31	4.36	38.35
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	2.47	6.93	49.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	2.77	4.62	41.54
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1.40	1.40	27.92
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	5.54	9.42	60.37
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	2.70	6.87	50.31
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	7.70	12.32	44.66
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	8.24	11.46	55.51
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1.38	6.92	45.70
CD8+ T Cells, donor1	11226-116C2	3.93	10.80	54.02
CD8+ T Cells, donor2	11307-117C2	2.25	6.76	47.30
CD8+ T Cells, donor3	11383-118B6	3.28	13.38	55.55
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	15.60	13.76	15.37
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	12.94	10.78	16.54
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	14.50	11.76	12.59
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	24.62	14.41	7.81
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.96	13.20	16.08
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	14.78	14.33	17.51
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	17.38	14.12	13.91
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	18.95	13.95	9.21
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	12.43	14.54	14.77
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	12.68	12.38	11.17
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.33	13.94	11.04
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	13.85	14.12	12.26
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	18.39	9.63	9.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	19.13	11.84	9.11
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	15.66	6.71	4.48
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.85	11.89	20.17
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	20.14	14.39	19.28
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	14.38	11.31	12.96
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	20.92	13.31	14.26
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	24.61	16.30	11.99
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	17.95	14.43	14.75
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	14.15	13.77	14.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.79	9.46	7.88
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.08	11.35	6.81
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	19.27	9.64	19.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	17.49	13.29	17.49
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	27.05	12.02	20.04
Cardiac Myocyte, donor1	11525-119I4	31.07	31.07	3.66
Cardiac Myocyte, donor2	11605-120I3	48.42	36.07	8.40
Cardiac Myocyte, donor3	11686-122I3	47.88	36.31	17.36
Chondrocyte - de diff, donor1	11261-116G1	38.13	31.20	18.37
Chondrocyte - de diff, donor2	11338-117F6	48.33	29.14	16.35
Chondrocyte - de diff, donor3	11410-118E6	41.98	25.37	14.22
Chondrocyte - re diff, donor2	11339-117F7	48.34	42.08	21.49
Chondrocyte - re diff, donor3	11411-118E7	26.69	39.63	27.10
Ciliary Epithelial Cells, donor1	11242-116D9	34.66	35.46	17.67
Ciliary Epithelial Cells, donor2	11323-117D9	47.46	43.18	20.74
Ciliary Epithelial Cells, donor3	11399-118D4	47.17	38.67	18.58
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	37.51	32.28	33.38
Corneal Epithelial Cells, donor1	11526-119I5	12.52	36.45	25.25
Corneal Epithelial Cells, donor2	11606-120I4	13.65	23.89	25.03
Corneal Epithelial Cells, donor3	11687-122I4	12.01	23.26	17.89
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	15.02	11.23	26.42
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9.15	9.78	27.13
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	0.00	27.61
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	10.69	11.34	23.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	5.12	12.30	44.41
Dendritic Cells - plasmacytoid, donor2	11309-117C4	7.18	9.79	45.70
Dendritic Cells - plasmacytoid, donor3	11385-118B8	3.39	11.61	60.49
Endothelial Cells - Aortic, donor0	11207-116A1	29.35	21.68	5.67
Endothelial Cells - Aortic, donor1	11263-116G3	31.10	30.51	4.69
Endothelial Cells - Aortic, donor2	11340-117F8	46.94	34.50	5.66
Endothelial Cells - Aortic, donor3	11412-118E8	31.85	23.20	3.93
Endothelial Cells - Artery, donor1	11264-116G4	34.61	40.43	7.85
Endothelial Cells - Artery, donor2	11341-117F9	52.00	37.64	8.47
Endothelial Cells - Artery, donor3	11413-118E9	58.55	40.15	7.54
Endothelial Cells - Lymphatic, donor1	11236-116D3	43.89	22.61	7.54
Endothelial Cells - Lymphatic, donor2	11317-117D3	39.86	31.64	10.04
Endothelial Cells - Lymphatic, donor3	11393-118C7	53.84	34.39	10.43
Endothelial Cells - Microvascular, donor1	11265-116G5	23.18	24.96	5.05
Endothelial Cells - Microvascular, donor2	11342-117G1	56.75	29.68	7.29
Endothelial Cells - Microvascular, donor3	11414-118F1	26.94	30.77	3.40
Endothelial Cells - Thoracic, donor1	11266-116G6	68.82	53.62	9.20
Endothelial Cells - Thoracic, donor2	11343-117G2	28.83	21.49	4.72
Endothelial Cells - Umbilical vein, donor1	11243-116E1	44.60	36.78	7.21
Endothelial Cells - Umbilical vein, donor2	11324-117E1	24.77	28.90	8.04
Endothelial Cells - Umbilical vein, donor3	11400-118D5	33.22	38.96	6.23
Endothelial Cells - Vein, donor1	11267-116G7	29.58	35.26	9.10
Endothelial Cells - Vein, donor2	11344-117G3	56.58	37.02	8.38
Endothelial Cells - Vein, donor3	11416-118F3	41.45	34.38	6.75
Eosinophils, donor1	12244-129H3	15.25	30.49	45.74
Eosinophils, donor2	12245-129H4	549.54	123.77	302.00
Eosinophils, donor3	12246-129H5	299.61	89.17	238.98
Esophageal Epithelial Cells, donor1	11507-119G4	16.13	32.50	17.84
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	24.96	52.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	48.81	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	58.70	40.64	12.32
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	70.18	36.46	14.45
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	23.40	31.63	12.46
Fibroblast - Aortic Adventitial, donor1	11245-116E3	67.43	41.96	17.10
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	79.97	22.11	10.24
Fibroblast - Aortic Adventitial, donor2	11326-117E3	46.51	39.55	21.20
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	94.07	41.37	15.28
Fibroblast - Aortic Adventitial, donor3	11401-118D6	66.44	58.80	21.59
Fibroblast - Cardiac, donor1	11268-116G8	34.48	26.76	18.60
Fibroblast - Cardiac, donor2	11345-117G4	40.17	31.08	15.92
Fibroblast - Cardiac, donor3	11417-118F4	42.58	39.43	17.98
Fibroblast - Cardiac, donor4	11452-119A3	57.89	42.74	11.82
Fibroblast - Cardiac, donor5	11456-119A7	35.41	35.15	9.64
Fibroblast - Cardiac, donor6	11460-119B2	50.94	43.51	13.04
Fibroblast - Choroid Plexus, donor1	11492-119E7	43.41	44.89	24.92
Fibroblast - Choroid Plexus, donor2	11572-120E6	24.16	27.18	17.69
Fibroblast - Choroid Plexus, donor3	11653-122E6	38.08	74.70	24.90
Fibroblast - Conjunctival, donor1	11531-120A1	50.74	78.88	23.06
Fibroblast - Conjunctival, donor3	11692-122I9	53.43	39.18	25.78
Fibroblast - Dermal, donor1	11269-116G9	69.03	61.51	12.68
Fibroblast - Dermal, donor2	11346-117G5	61.32	51.88	15.09
Fibroblast - Dermal, donor3	11418-118F5	93.44	53.19	12.69
Fibroblast - Dermal, donor4	11450-119A1	39.23	52.34	13.11
Fibroblast - Dermal, donor5	11454-119A5	54.43	52.68	11.51
Fibroblast - Dermal, donor6	11458-119A9	52.46	57.82	15.27
Fibroblast - Gingival, donor1	11237-116D4	155.55	66.63	17.91
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	89.60	49.78	17.29
Fibroblast - Gingival, donor2	11318-117D4	55.61	47.05	10.67
Fibroblast - Gingival, donor3	11394-118C8	137.97	75.22	16.05
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	44.67	41.56	5.19
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	32.42	28.19	11.10
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	48.17	39.44	10.29
Fibroblast - Gingival, donor6 (control)	11922-125H5	44.76	32.73	7.98
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	56.81	49.05	10.23
Fibroblast - Gingival, donor7 (control)	11924-125H7	36.85	35.68	11.26
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	48.27	36.27	13.77
Fibroblast - Gingival, donor8 (control)	11926-125H9	58.91	35.10	13.16
Fibroblast - Gingival, donor9 (control)	11927-125I1	35.95	35.22	12.62
Fibroblast - Lung, donor1	11270-116H1	35.34	28.55	6.80
Fibroblast - Lung, donor2	11347-117G6	59.69	58.19	20.89
Fibroblast - Lung, donor3	11419-118F6	77.24	62.04	13.51
Fibroblast - Lymphatic, donor1	11506-119G3	132.45	159.94	37.49
Fibroblast - Lymphatic, donor2	11586-120G2	83.92	110.49	34.97
Fibroblast - Lymphatic, donor3	11667-122G2	47.58	59.61	12.31
Fibroblast - Mammary, donor1	11540-120B1	143.71	144.52	37.76
Fibroblast - Mammary, donor2	11620-122A9	107.84	67.90	19.97
Fibroblast - Mammary, donor3	11701-123A9	148.91	113.17	17.87
Fibroblast - Periodontal Ligament, donor1	11238-116D5	44.23	43.26	15.91
Fibroblast - Periodontal Ligament, donor2	11319-117D5	80.69	78.72	16.08
Fibroblast - Periodontal Ligament, donor3	11395-118C9	181.76	100.06	17.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	51.14	52.66	15.26
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	57.51	39.15	11.07
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	43.61	33.52	12.64
Fibroblast - Pulmonary Artery, donor1	11250-116E8	40.90	34.04	10.94
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	156.86	116.43	23.37
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	88.87	67.49	21.38
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	53.77	43.89	13.84
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	58.94	21.83	11.91
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	42.45	36.94	11.72
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	48.68	36.26	18.33
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	114.02	54.76	24.37
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	47.93	51.82	25.04
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	42.77	17.72	7.09
Fibroblast - skin normal, donor1	11553-120C5	68.58	53.00	14.44
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	104.26	29.68	21.65
Fibroblast - skin normal, donor2	11561-120D4	38.88	47.32	24.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	46.24	22.67	8.76
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	50.29	31.65	11.43
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	38.29	45.13	28.72
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	108.71	43.68	23.65
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	73.07	58.91	22.16
Fibroblast - skin walker warburg, donor1	11554-120C6	70.34	49.76	12.82
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	25.25	20.07	5.96
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	2.61	11.33	26.15
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.01	14.39	9.19
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	11.97	23.68	8.07
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	10.22	23.00	11.75
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	11.48	16.84	12.25
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8.29	13.40	9.57
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	8.84	20.54	15.12
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	3.03	24.82	21.51
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	9.13	31.51	22.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	8.92	30.12	19.02
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	5.02	29.87	20.62
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	9.13	32.94	23.81
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	7.96	18.57	13.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	8.20	27.13	17.67
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	6.90	22.17	15.52
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.91	22.03	11.01
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	14.00	34.19	17.84
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	10.80	30.45	14.26
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.21	20.74	12.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	16.43	31.72	11.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	13.33	28.53	13.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	17.92	29.29	13.33
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	16.84	30.14	19.21
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	12.56	28.14	15.90
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	15.86	29.94	14.08
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	17.54	33.67	16.33
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	13.57	33.42	19.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	30.15	30.41	11.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.68	47.35	17.79
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.57	38.77	16.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	12.06	36.63	17.82
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.05	33.36	11.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.40	21.85	12.25
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	15.06	36.93	15.68
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	11.88	32.63	21.79
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	18.34	38.36	14.51
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	10.58	28.44	16.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	9.22	30.63	23.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	15.56	36.31	18.15
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	12.51	28.22	22.77
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	8.24	26.15	21.70
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.60	33.22	14.24
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	13.68	22.81	12.77
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	9.41	25.51	21.12
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	14.49	30.52	19.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	13.75	22.72	21.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	9.91	26.02	10.55
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	17.92	27.81	9.09
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	15.45	29.84	10.40
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	10.10	27.85	12.18
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	14.37	33.07	18.16
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	13.46	28.57	16.78
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	11.18	25.00	21.05
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	18.84	38.68	32.73
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	17.15	27.31	13.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.52	32.68	13.11
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	21.86	52.87	65.57
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	6.97	24.48	20.30
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	4.78	23.11	17.72
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	7.77	28.23	22.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	8.45	21.91	6.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	7.91	14.69	8.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	13.37	20.29	15.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	17.32	14.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	12.38	23.21	13.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	22.46	12.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	10.43	22.60	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	10.09	17.58	11.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	19.35	24.71	8.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	26.66	26.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	11.47	18.18	13.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	10.79	20.26	8.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	7.55	19.29	8.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	14.00	20.67	9.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	11.55	25.81	9.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	22.97	8.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	10.88	30.93	12.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	10.66	25.75	9.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	22.02	8.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	11.18	21.54	7.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.74	23.70	13.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	10.54	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	11.92	19.99	11.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	7.82	22.17	12.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	13.38	19.40	7.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	13.48	32.36	16.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	13.35	26.36	18.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	2.48	14.91	19.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	8.97	36.80	18.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	6.64	28.36	22.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	8.65	26.45	21.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	10.77	26.32	22.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	12.83	25.65	24.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	9.44	27.15	17.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	12.25	23.92	15.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	13.61	33.36	20.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	10.17	25.43	11.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	4.78	21.49	20.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	11.16	21.84	15.53
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	22.83	10.27
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	26.20	33.68	12.89
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	53.97	41.60	7.87
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	57.09	40.28	13.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	62.66	37.18	19.63
Hep-2 cells mock treated, biol_rep1	11898-125E8	93.53	66.26	18.10
Hep-2 cells mock treated, biol_rep2	11899-125E9	91.49	60.43	18.06
Hep-2 cells mock treated, biol_rep3	11900-125F1	87.13	63.70	22.30
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	100.13	64.93	16.18
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	87.25	70.28	18.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	80.52	59.20	20.02
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	96.77	63.51	14.07
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	91.61	63.64	17.33
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	82.98	65.04	17.62
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	30.22	41.97	7.83
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	81.80	62.76	10.82
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	34.37	10.58
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	92.41	71.60	24.69
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	59.57	58.12	21.07
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	39.16	41.09	12.94
Hepatocyte, donor1	11523-119I2	84.74	29.05	21.79
Hepatocyte, donor2	11603-120I1	209.00	40.94	22.62
Hepatocyte, donor3	11684-122I1	119.64	41.11	35.59
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	2.61	5.22	40.47
Intestinal epithelial cells (polarized), donor1	11246-116E4	28.14	34.26	34.96
Iris Pigment Epithelial Cells, donor1	11530-119I9	57.49	58.59	20.17
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	19.10	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	33.38	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	8.31	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	5.01	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	35.60	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	28.19	12.81
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	18.28	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	12.99	8.12
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	20.01	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	21.78	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	21.18	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	16.63	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	15.71	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	4.41	8.19	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	15.47	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.81	12.92	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	30.59	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1.63	13.85	5.70
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.62	15.11	4.20
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.82	17.68	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2.77	24.01	3.69
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	30.16	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2.36	14.16	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	17.23	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	4.30	10.76	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	7.62	13.98	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2.55	12.75	4.46
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	16.40	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	4.28	12.85	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	3.40	14.51	1.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	21.07	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	22.00	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	7.65	18.78	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	17.70	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	6.48	9.73
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	2.62	24.41	5.23
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	13.50	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	13.94	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	3.20	10.67	12.80
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	27.71	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	14.25	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	13.81	7.36
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	6.05	18.15
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	6.21	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	17.98	8.46
Keratinocyte - epidermal, donor1	11272-116H3	15.18	21.79	15.10
Keratinocyte - epidermal, donor2	11349-117G8	7.61	16.40	6.44
Keratinocyte - epidermal, donor3	11421-118F8	7.00	18.84	13.54
Keratinocyte - oral, donor1	11251-116E9	18.16	46.20	24.41
Keratocytes, donor1	11527-119I6	50.20	55.01	20.63
Keratocytes, donor2	11607-120I5	65.62	63.28	12.89
Keratocytes, donor3	11688-122I5	23.51	28.06	6.92
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	0.00	15.39
Lens Epithelial Cells, donor1	11529-119I8	36.68	51.78	15.10
Lens Epithelial Cells, donor2	11609-120I7	35.52	50.28	17.53
Lens Epithelial Cells, donor3	11690-122I7	63.17	50.05	22.70
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	14.47	20.04	5.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.44	11.44	4.19
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.91	15.11	3.78
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.99	9.68	5.91
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	13.55	14.18	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	12.72	14.66	3.34
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	8.62	10.26	3.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	13.40	12.14	2.53
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.82	13.65	3.38
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	14.63	3.96
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	11.44	9.89	3.88
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	11.29	14.07	5.18
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.24	13.94	4.53
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.31	16.22	3.82
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	13.32	13.73	4.26
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	13.24	13.86	3.70
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.61	11.53	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	14.82	19.95	5.12
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.19	10.20	4.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.64	14.35	4.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	14.94	14.69	4.98
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.21	11.15	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	10.77	12.66	2.96
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	12.26	12.87	4.09
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.78	12.96	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	12.56	13.61	3.35
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	12.18	15.04	3.91
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.82	15.82	2.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.60	11.67	3.76
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	10.82	15.80	4.56
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.18	13.57	3.39
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.92	7.94	4.30
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	11.03	15.49	4.34
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	12.22	15.92	4.81
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	10.38	8.89	2.72
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.07	12.92	3.99
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.90	13.83	6.11
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	14.00	10.96	2.74
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.06	13.58	2.66
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.89	13.16	3.20
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	13.57	16.48	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	12.45	13.23	2.96
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.88	15.40	3.22
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.33	13.72	4.90
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	11.54	13.89	2.83
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	21.29	21.16	5.20
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.04	12.29	2.05
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.85	16.71	3.88
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	20.39	9.06
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.97	28.38	6.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2.97	23.01	11.13
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	12.27	21.58	7.62
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	26.73	4.22
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	28.02	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.64	21.64	8.24
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	21.41	7.14
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	11.08	20.81	6.79
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.23	17.74	6.98
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	8.55	13.96	6.30
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.45	29.67	8.40
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	12.84	23.62	4.11
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.17	19.41	9.53
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.66	18.66	7.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	9.68	19.36	6.11
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	13.87	25.35	7.20
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.96	22.11	8.69
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	10.43	19.02	6.75
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	14.68	30.17	11.42
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.41	21.87	9.58
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	9.81	18.78	6.17
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	26.79	8.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.90	26.71	6.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	11.06	17.94	5.98
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.30	23.24	7.75
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	14.14	26.16	9.90
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	10.69	18.44	7.01
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	20.72	11.51
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.97	28.78	9.21
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	14.15	25.48	7.93
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	6.56	23.79	9.03
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	14.91	24.85	11.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	9.34	20.11	6.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.96	38.09	10.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	12.26	28.24	11.52
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.91	19.81	8.61
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	25.69	5.99
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	13.99	26.65	11.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	22.93	4.83
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.95	29.86	11.38
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	10.31	29.56	9.62
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	14.49	20.93	6.98
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	15.49	35.69	7.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.11	27.78	11.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	11.63	8.14
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	28.56	12.69
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	16.01	29.61	11.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.18	20.35	7.27
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.96	29.89	9.96
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	15.78	33.54	10.85
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	18.82	8.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	8.05	31.17	10.06
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	11.72	23.88	9.01
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	18.93	15.49
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.91	30.28	14.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	11.34	25.03	6.26
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.90	18.47	7.26
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	8.82	28.02	6.75
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	6.56	24.07	8.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	8.39	17.33	5.03
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.83	27.82	8.83
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	13.11	15.43	5.79
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	10.63	18.74	4.05
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.02	24.99	10.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.13	25.44	6.76
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	8.51	15.80	4.86
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	5.53	20.06	5.53
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	11.02	31.92	9.88
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	13.94	14.98	6.71
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	8.47	24.79	9.67
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	15.85	29.79	9.51
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	13.86	23.46	7.46
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.19	22.41	5.75
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	14.40	31.37	11.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	15.56	23.34	11.32
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.94	31.78	11.35
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	14.14	29.54	9.98
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	16.44	14.09	6.26
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.44	20.88	12.94
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	12.08	26.48	9.76
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	11.37	18.06	6.69
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.76	31.54	8.55
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	11.72	23.03	12.93
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	18.36	23.86	6.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	11.56	32.01	15.11
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.68	35.90	13.68
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	17.64	23.77	9.97
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.21	27.36	9.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.92	37.86	11.14
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	23.92	27.56	9.62
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.27	25.86	10.61
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	37.41	22.86
Macrophage - monocyte derived, donor1	11232-116C8	6.38	12.54	11.17
Macrophage - monocyte derived, donor2	11313-117C8	19.64	17.80	29.73
Macrophage - monocyte derived, donor3	11389-118C3	16.12	19.27	21.76
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.84	11.15	5.84
Mallassez-derived cells, donor2	11929-125I3	10.77	15.37	7.45
Mallassez-derived cells, donor3	11930-125I4	11.54	21.13	7.23
Mammary Epithelial Cell, donor1	11273-116H4	21.62	24.51	13.45
Mammary Epithelial Cell, donor2	11350-117G9	12.16	23.16	9.27
Mammary Epithelial Cell, donor3	11422-118F9	9.23	25.44	7.73
Mast cell - stimulated, donor1	11487-119E2	13.56	10.85	7.46
Mast cell, donor1	11563-120D6	13.63	24.55	13.52
Mast cell, donor2	11565-120D8	10.70	29.72	30.91
Mast cell, donor3	11566-120D9	8.55	16.43	38.27
Mast cell, donor4	11567-120E1	15.42	24.11	39.89
Mast cell, expanded and stimulated, donor5	11940-126A5	9.54	17.19	31.72
Mast cell, expanded and stimulated, donor8	11942-126A7	15.76	9.92	5.25
Mast cell, expanded, donor5	11939-126A4	6.08	13.08	16.41
Mast cell, expanded, donor8	11941-126A6	9.21	11.88	12.89
Melanocyte - dark, donor1	11502-119F8	27.86	26.07	5.17
Melanocyte - dark, donor2	11582-120F7	48.80	39.80	10.04
Melanocyte - dark, donor3	11663-122F7	6.16	21.59	8.33
Melanocyte - light, donor1	11274-116H5	6.82	19.75	7.52
Melanocyte - light, donor2	11351-117H1	4.78	19.11	6.82
Melanocyte - light, donor3	11423-118G1	19.08	28.62	6.94
Melanocyte, donor1 (MC+1)	12641-134G4	9.37	28.53	11.14
Melanocyte, donor2 (MC+2)	12739-135I3	10.22	18.29	7.26
Melanocyte, donor3 (MC+3)	12837-137B2	11.79	30.27	6.43
Meningeal Cells, donor1	11493-119E8	72.70	86.47	24.32
Meningeal Cells, donor2	11573-120E7	39.17	62.50	26.85
Meningeal Cells, donor3	11654-122E7	56.48	38.31	9.86
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	40.49	41.06	15.11
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	30.09	19.22	6.54
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	46.00	34.17	9.20
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	78.49	69.33	14.39
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	53.10	38.03	8.61
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	44.05	40.66	10.59
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	42.22	44.23	11.56
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	72.52	51.64	21.98
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	69.41	46.76	24.11
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	64.25	55.24	17.80
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	33.93	41.28	17.31
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	66.54	36.06	22.68
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	81.71	42.10	9.21
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	50.74	28.49	35.91
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	60.72	32.70	14.01
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	51.87	63.40	12.81
Mesenchymal stem cells - adipose, donor0	11217-116B2	43.24	44.66	14.53
Mesenchymal stem cells - hepatic, donor0	11218-116B3	62.23	30.02	7.82
Mesenchymal stem cells - umbilical, donor0	11214-116A8	47.90	61.68	21.05
Mesothelial Cells, donor1	11247-116E5	115.09	48.00	20.42
Mesothelial Cells, donor2	12156-128G5	62.06	41.54	16.52
Mesothelial Cells, donor3	11402-118D7	109.55	55.43	19.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	8.10	27.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.07	20.19	25.61
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	29.74	15.61	28.27
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	10.37	17.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	9.92	11.78	14.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	21.37	14.11	19.71
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	18.53
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.76	19.52	24.28
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	25.14	15.83	24.67
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	58.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.63	14.83	20.32
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	21.38	11.88	21.38
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	12.39	10.62	13.27
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.94	11.78	20.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	5.26	7.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.01	15.07	15.92
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	6.45	14.73
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.11	15.50	16.69
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	1.68	25.15
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	33.95
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	9.53	12.04	15.56
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	19.96	11.88	19.25
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	7.19	20.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.51	14.28	14.74
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.98	13.04	18.30
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	13.45	9.78	17.12
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.08	9.87	15.02
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.01	10.45	16.45
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.17	11.61	12.48
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.24	10.14	18.25
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	6.63	19.88
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	12.50	13.32	11.96
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	15.29	11.76	19.41
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	2.18	10.90
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	14.90	8.17	16.34
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	22.41	9.61	19.21
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	10.97	13.71
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	11.51	14.02	18.52
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	8.15	20.39
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	18.83	10.95	16.64
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	8.83	23.18
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	18.57	8.33	12.81
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	24.54	15.12	16.86
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	9.74	13.22
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	28.73	8.84	26.52
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	31.45	14.02	11.97
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.88	7.88	16.63
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	23.79	6.39	19.18
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	40.40	19.36	14.31
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	15.38	10.81	17.46
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.90	11.65	12.24
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	34.69	13.27	11.16
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	28.38	14.19	10.85
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	43.41	15.70	17.55
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	18.21	11.95	18.21
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	24.18	16.58	10.09
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	34.99	17.88	10.37
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.87	15.87	15.87
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	14.61	10.16	12.70
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	24.82	16.55	10.14
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	18.86	16.76	15.86
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.66	11.44	8.05
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	27.39	11.78	9.87
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	20.34	13.93	13.49
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	18.20	6.45	6.07
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	28.98	18.47	12.50
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	25.56	17.21	13.76
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.34	12.38	7.17
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.11	14.11	7.94
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	24.22	16.72	13.26
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	16.90	14.01	12.78
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	15.48	14.00	10.42
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	15.07	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	5.35	10.69
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	8.87	20.04	11.17
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	14.73	9.47	21.04
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	5.73	10.08	8.90
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	15.83	15.83	25.15
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	8.64	16.15	9.76
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	13.85	10.92	22.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	7.35	11.42	6.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	14.00	7.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.96	16.86	8.06
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	9.33	14.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	12.83	6.95
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	7.73	11.59
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	18.18	11.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.07	17.71	24.46
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	8.17	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	0.64	3.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	3.24	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	7.55	15.10
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	9.79	19.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	25.10	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	26.28	23.70	13.36
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.90	18.29	8.36
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	39.38	52.06	6.01
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	37.15	31.72	19.20
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	12.93	23.20	11.79
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	28.73	52.66	14.36
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	24.48	32.64	8.16
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.00	26.37	3.77
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	32.08	38.58	9.76
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	22.16	24.86	6.22
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	16.19	26.28	15.35
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	30.77	25.31	8.93
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.85	12.99	6.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	23.80	25.84	5.67
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.33	18.45	8.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	21.14	23.15	12.76
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	25.99	28.11	11.67
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	25.81	29.41	3.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	8.53	6.24	7.55
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	20.17	22.60	9.11
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	20.11	23.28	11.46
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	21.80	20.39	11.95
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	17.01	21.15	9.19
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.39	21.53	9.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	12.42	12.76	7.93
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	15.17	12.64
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.27	20.94	10.25
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	15.24	13.13	9.31
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.82	14.95	11.63
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	20.17	32.62	7.73
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	24.33	28.32	12.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	17.13	19.84	12.62
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.87	8.73	8.33
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	23.22	19.50	5.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.24	27.62	15.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	21.51	23.14	6.84
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.12	27.02	10.46
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	16.73	23.52	17.64
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	20.28	20.28	11.46
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.28	25.26	7.31
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	18.85	26.79	8.43
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	22.97	23.74	10.34
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.08	23.89	24.50
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	15.03	15.25	15.91
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	16.26	6.10
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.12	25.00	9.75
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.31	18.57	16.37
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.04	20.28	14.83
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.08	26.11	4.75
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	12.47	7.94	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	99.26	36.27	17.27
Myoblast, donor2	11322-117D8	143.27	53.51	25.12
Myoblast, donor3	11398-118D3	69.45	46.58	20.85
NK T cell leukemia cell line:KHYG-1	10777-110G3	4.09	17.95	16.93
Natural Killer Cells, donor1	11230-116C6	8.30	15.99	50.43
Natural Killer Cells, donor2	11311-117C6	5.43	15.98	47.34
Natural Killer Cells, donor3	11387-118C1	10.86	20.98	38.28
Neural stem cells, donor1	11275-116H6	23.95	22.14	21.05
Neural stem cells, donor2	11352-117H2	26.96	42.36	65.47
Neurons, donor1	11494-119E9	12.52	19.34	42.10
Neurons, donor2	11574-120E8	9.91	17.39	38.53
Neurons, donor3	11655-122E8	7.40	12.33	36.18
Neutrophils, donor1	11233-116C9	451.94	127.14	242.21
Neutrophils, donor2	11314-117C9	315.98	113.06	197.12
Neutrophils, donor3	11390-118C4	426.37	136.22	290.15
Nucleus Pulposus Cell, donor1	11252-116F1	86.44	42.27	21.37
Nucleus Pulposus Cell, donor2	11409-118E5	66.75	51.45	17.91
Nucleus Pulposus Cell, donor3	11462-119B4	42.12	45.93	18.25
Olfactory epithelial cells, donor1	11933-125I7	45.84	35.93	8.81
Olfactory epithelial cells, donor2	11934-125I8	46.17	33.58	9.70
Olfactory epithelial cells, donor3	11935-125I9	37.57	31.78	7.72
Olfactory epithelial cells, donor4	11936-126A1	73.83	46.36	16.36
Oligodendrocyte - precursors, donor1	11496-119F2	92.68	85.46	25.28
Osteoblast - differentiated, donor1	11276-116H7	82.10	47.22	50.20
Osteoblast - differentiated, donor2	11353-117H3	26.29	22.86	20.58
Osteoblast - differentiated, donor3	11425-118G3	44.69	29.17	31.04
Osteoblast, donor1	11277-116H8	35.57	40.26	15.63
Osteoblast, donor2	11354-117H4	40.73	51.27	20.37
Osteoblast, donor3	11426-118G4	47.45	51.72	22.75
Pancreatic stromal cells, donor1	11249-116E7	32.09	36.05	10.36
Pericytes, donor1	11491-119E6	26.70	39.94	19.36
Pericytes, donor2	11571-120E5	14.26	30.56	30.33
Pericytes, donor3	11652-122E5	113.12	62.66	22.79
Perineurial Cells, donor1	11499-119F5	53.12	50.86	17.07
Perineurial Cells, donor2	11579-120F4	54.19	40.94	11.41
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	28.69	21.36	36.97
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	32.08	16.41	34.53
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	26.14	18.51	33.00
Placental Epithelial Cells, donor1	11278-116H9	3.35	9.81	27.74
Placental Epithelial Cells, donor2	11355-117H5	13.31	27.72	29.94
Placental Epithelial Cells, donor3	11427-118G5	10.80	23.17	31.61
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	44.30	36.08	12.97
Preadipocyte - breast, donor1	11467-119B9	51.96	30.20	9.57
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	29.37	10.18	6.66
Preadipocyte - breast, donor2	11328-117E5	42.55	33.55	19.36
Preadipocyte - omental, donor1	11468-119C1	83.97	42.73	15.45
Preadipocyte - omental, donor2	11329-117E6	69.84	38.41	17.90
Preadipocyte - omental, donor3	11403-118D8	89.53	58.88	25.07
Preadipocyte - perirenal, donor1	11469-119C2	127.95	76.77	26.58
Preadipocyte - subcutaneous, donor1	11279-116I1	60.50	53.44	18.73
Preadipocyte - subcutaneous, donor2	11356-117H6	58.44	55.25	24.26
Preadipocyte - subcutaneous, donor3	11428-118G6	49.04	51.26	21.80
Preadipocyte - visceral, donor1	11280-116I2	82.81	70.14	19.28
Preadipocyte - visceral, donor2	11357-117H7	70.87	47.40	17.03
Preadipocyte - visceral, donor3	11429-118G7	54.44	59.46	16.51
Prostate Epithelial Cells (polarized), donor1	11253-116F2	36.36	40.88	23.38
Prostate Epithelial Cells, donor2	11331-117E8	14.49	21.80	14.62
Prostate Epithelial Cells, donor3	11404-118D9	18.86	17.64	42.50
Prostate Stromal Cells, donor1	11254-116F3	37.36	27.56	12.42
Prostate Stromal Cells, donor2	11332-117E9	44.65	36.04	12.91
Prostate Stromal Cells, donor3	11405-118E1	37.12	31.49	11.05
Renal Cortical Epithelial Cells, donor1	11516-119H4	63.14	80.30	20.07
Renal Cortical Epithelial Cells, donor2	11596-120H3	55.17	41.38	16.63
Renal Epithelial Cells, donor1	11517-119H5	66.45	64.93	24.85
Renal Epithelial Cells, donor2	11597-120H4	59.04	54.77	20.63
Renal Epithelial Cells, donor3	11678-122H4	56.85	47.75	16.09
Renal Glomerular Endothelial Cells, donor1	11514-119H2	35.40	46.30	8.17
Renal Glomerular Endothelial Cells, donor2	11594-120H1	40.97	41.37	10.24
Renal Glomerular Endothelial Cells, donor3	11675-122H1	48.62	44.62	18.65
Renal Glomerular Endothelial Cells, donor4	11783-124B1	49.24	43.25	9.32
Renal Mesangial Cells, donor1	11518-119H6	89.80	77.91	24.21
Renal Mesangial Cells, donor2	11598-120H5	77.75	77.75	20.06
Renal Mesangial Cells, donor3	11679-122H5	80.45	67.41	27.46
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	85.90	75.43	22.28
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	87.29	65.36	19.82
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	64.22	69.81	16.78
Retinal Pigment Epithelial Cells, donor0	11215-116A9	22.82	37.34	12.45
Retinal Pigment Epithelial Cells, donor1	11528-119I7	59.98	55.43	13.93
Retinal Pigment Epithelial Cells, donor2	11608-120I6	33.96	61.75	12.35
Retinal Pigment Epithelial Cells, donor3	11689-122I6	28.85	20.07	11.04
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	97.55	44.77	35.41
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	7.15	11.61	12.51
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	9.91	9.36	11.56
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	4.64	3.48	9.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	21.32	30.82	15.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	28.00	28.80	13.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	32.57	31.57	14.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	23.44	27.66	20.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	30.88	32.87	17.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	25.19	35.13	15.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	20.13	39.43	20.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	25.57	26.17	14.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	24.19	21.86	15.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	24.10	32.99	20.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	29.83	30.80	15.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	30.09	32.08	17.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	18.93	36.51	22.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	27.67	29.53	17.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	33.07	30.44	15.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	22.96	34.90	16.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.35	28.91	14.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	29.98	32.46	19.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	19.33	35.56	19.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	28.31	23.55	14.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	30.25	31.45	11.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	20.97	35.55	20.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	25.14	26.37	15.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	29.68	35.06	13.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	23.59	38.92	16.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	26.98	28.17	13.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	30.40	30.40	13.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	23.02	38.98	24.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	26.99	25.00	12.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	24.86	27.15	17.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	22.21	38.22	22.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	25.20	27.25	13.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	27.57	26.61	18.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	20.63	36.79	20.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	27.30	29.08	13.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	21.67	25.77	15.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	20.79	39.20	17.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	29.30	37.58	18.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	31.99	33.59	18.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	14.52	28.48	13.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	21.43	33.33	16.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	31.04	37.29	18.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	14.41	29.38	20.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	18.87	20.61	15.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	10.58	14.81	17.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	13.58	24.35	21.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	20.38	20.52	16.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	9.13	18.86	20.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	11.15	25.02	24.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	19.00	21.04	22.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	10.78	22.47	24.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	10.98	18.66	23.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	9.61	18.78	16.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	8.41	23.44	18.63
Schwann Cells, donor1	11498-119F4	47.39	76.73	21.06
Schwann Cells, donor2	11578-120F3	20.41	20.41	17.01
Schwann Cells, donor3	11659-122F3	34.83	46.23	17.96
Sebocyte, donor1	11220-116B5	23.55	67.92	30.13
Sebocyte, donor2	11301-117B5	12.41	28.95	18.38
Sebocyte, donor3	11378-118B1	31.54	40.19	16.90
Sertoli Cells, donor1	11255-116F4	144.12	67.92	18.22
Sertoli Cells, donor2	11333-117F1	115.80	42.37	19.77
Skeletal Muscle Cells, donor1	11281-116I3	34.49	36.42	23.05
Skeletal Muscle Cells, donor2	11358-117H8	10.12	17.35	7.95
Skeletal Muscle Cells, donor3	11430-118G8	51.83	66.05	20.06
Skeletal Muscle Cells, donor4	11451-119A2	44.61	45.71	12.88
Skeletal Muscle Cells, donor5	11455-119A6	45.93	41.47	13.53
Skeletal Muscle Cells, donor6	11459-119B1	50.63	50.79	12.93
Skeletal Muscle Satellite Cells, donor1	11240-116D7	58.21	44.73	14.24
Skeletal Muscle Satellite Cells, donor2	11321-117D7	61.36	46.09	15.27
Skeletal Muscle Satellite Cells, donor3	11397-118D2	52.38	51.79	16.77
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	19.38	23.84	23.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	34.74	41.25	16.65
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	21.05	24.22	15.14
Skin - palm, donor1	10286-104F7	0.00	8.06	59.09
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	16.58	22.06	11.53
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	35.17	31.90	22.08
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.54	19.73	7.40
Small Airway Epithelial Cells, donor1	11256-116F5	22.52	19.32	12.37
Small Airway Epithelial Cells, donor2	11334-117F2	17.30	20.68	12.38
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	32.35	33.62	16.49
Small Airway Epithelial Cells, donor3	11406-118E2	14.62	18.06	22.49
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	50.92	98.13	48.45
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	228.78	69.59	37.57
Smooth Muscle Cells - Aortic, donor0	11210-116A4	149.31	83.47	24.69
Smooth Muscle Cells - Aortic, donor1	11283-116I5	94.36	52.60	12.82
Smooth Muscle Cells - Aortic, donor2	11360-117I1	99.23	56.70	22.84
Smooth Muscle Cells - Aortic, donor3	11432-118H1	154.51	81.12	40.17
Smooth Muscle Cells - Bladder, donor1	11519-119H7	23.02	21.02	7.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	121.90	54.56	23.95
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	65.83	49.43	18.62
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	45.32	35.46	19.84
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	22.14	28.65	8.79
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	46.96	41.35	15.36
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	54.95	38.72	9.11
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	90.77	69.30	22.45
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	33.18	25.57	19.48
Smooth Muscle Cells - Carotid, donor1	11285-116I7	97.49	54.05	23.99
Smooth Muscle Cells - Carotid, donor2	11362-117I3	134.66	195.86	12.24
Smooth Muscle Cells - Carotid, donor3	11434-118H3	66.76	39.58	15.74
Smooth Muscle Cells - Colonic, donor1	11239-116D6	36.43	29.94	7.67
Smooth Muscle Cells - Colonic, donor2	11320-117D6	45.63	37.02	9.69
Smooth Muscle Cells - Colonic, donor3	11396-118D1	49.33	46.39	10.18
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	122.20	55.22	23.98
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	106.71	46.35	24.79
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	82.48	46.92	18.83
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	60.43	57.70	12.29
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	65.18	40.52	10.92
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	117.75	58.88	39.45
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	139.94	50.29	20.02
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	115.93	69.44	32.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	43.18	52.46	15.37
Smooth Muscle Cells - Prostate, donor1	11257-116F6	35.55	43.54	16.91
Smooth Muscle Cells - Prostate, donor2	11335-117F3	28.30	33.43	12.40
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.00	25.11	10.91
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	138.41	64.53	28.19
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	81.77	49.51	24.01
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	115.01	183.49	7.75
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	155.80	69.30	34.88
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	112.08	55.03	27.26
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	99.66	49.52	17.55
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	81.71	66.08	20.94
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	65.48	64.56	19.74
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	32.23	41.58	16.82
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	58.57	45.91	17.27
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	46.66	38.75	16.06
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	37.79	45.13	18.62
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.98	40.11	9.50
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	43.15	50.44	13.15
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	32.86	33.33	8.10
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	51.87	40.86	17.13
Smooth Muscle Cells - Uterine, donor1	11258-116F7	54.57	42.86	30.71
Smooth Muscle Cells - Uterine, donor3	11466-119B8	32.18	29.84	15.51
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.52	19.05	5.05
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	42.05	28.83	11.64
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	31.24	11.16	4.46
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	69.71	31.98	16.17
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	50.53	26.97	10.50
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	28.36	23.63	9.85
Smooth muscle cells - airway, control, donor1	11966-126D4	40.38	25.14	14.22
Smooth muscle cells - airway, control, donor2	11967-126D5	22.36	15.97	10.78
Smooth muscle cells - airway, control, donor3	11968-126D6	26.75	14.63	9.61
Smooth muscle cells - airway, control, donor4	11969-126D7	15.13	11.92	8.25
Synoviocyte, donor1	11291-117A4	49.32	27.44	13.47
Synoviocyte, donor2	11368-117I9	52.13	31.85	21.12
Synoviocyte, donor3	11440-118H9	35.08	26.59	19.21
Trabecular Meshwork Cells, donor1	11532-120A2	75.04	79.68	17.15
Trabecular Meshwork Cells, donor2	11612-122A1	75.32	53.52	21.80
Trabecular Meshwork Cells, donor3	11693-123A1	77.80	62.05	11.11
Tracheal Epithelial Cells, donor1	11292-117A5	12.76	18.42	10.25
Tracheal Epithelial Cells, donor2	11369-118A1	16.62	22.42	10.05
Tracheal Epithelial Cells, donor3	11441-118I1	12.60	22.33	8.02
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	89.32	43.30	36.78
Urethra, donor2	10319-105A4	12.59	17.98	53.95
Urothelial Cells, donor1	11520-119H8	19.66	34.00	14.35
Urothelial Cells, donor2	11600-120H7	10.41	23.23	16.42
Urothelial Cells, donor3	11681-122H7	13.06	29.34	17.65
Urothelial cells, donor0	11216-116B1	14.93	32.10	8.69
Whole blood (ribopure), donor090309, donation1	12179-129A1	79.19	47.16	97.88
Whole blood (ribopure), donor090309, donation2	12180-129A2	104.36	42.89	102.93
Whole blood (ribopure), donor090309, donation3	12181-129A3	62.98	30.12	71.87
Whole blood (ribopure), donor090325, donation1	12176-128I7	59.57	29.61	54.41
Whole blood (ribopure), donor090325, donation2	12177-128I8	63.33	12.20	52.29
Whole blood (ribopure), donor090612, donation1	12182-129A4	80.18	30.20	105.17
Whole blood (ribopure), donor090612, donation2	12183-129A5	58.74	39.47	103.71
Whole blood (ribopure), donor090612, donation3	12184-129A6	63.90	25.56	63.90
Wilms' tumor cell line:G-401	10809-111A8	22.45	32.69	9.01
Wilms' tumor cell line:HFWT	10597-108E3	14.96	17.60	19.36
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	8.66	29.33	7.82
achilles tendon, donor2	10292-104G4	24.80	24.80	35.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	26.01	34.16	21.42
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	207.80	104.71	29.49
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	3.44	11.63	17.21
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	3.81	12.79	53.06
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	63.52	74.49	24.74
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	1.90	2.96	5.08
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	15.79	18.78	11.98
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	7.93	18.95	13.22
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	40.84	65.34	35.94
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	5.44	15.14	9.32
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	5.15	15.46	8.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	15.60	19.50
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	7.20	17.43	11.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2.33	12.17	9.32
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	4.68	14.32	9.35
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	5.58	20.45	4.65
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	7.40	16.45	5.35
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.92	13.51	5.83
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	2.56	9.39	6.40
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	2.43	9.40	6.67
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	4.33	7.22	5.78
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	8.69	19.60	8.91
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	18.01	21.35	9.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	20.44	48.31	24.16
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	19.59	35.78	19.59
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	4.80	16.57	8.72
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	22.49	22.49
adenocarcinoma cell line:IM95m	10796-110I4	26.85	55.81	15.07
adipose tissue, adult, pool1	10010-101C1	43.74	27.46	28.39
adipose, donor1	10184-103D4	5.28	12.31	8.80
adipose, donor2	10185-103D5	5.27	26.36	27.98
adipose, donor3	10186-103D6	12.80	39.48	22.60
adipose, donor4	10187-103D7	32.94	123.95	15.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	2.21	15.62	23.20
adrenal gland, adult, pool1	10081-102A9	87.30	40.01	50.93
adult T-cell leukemia cell line:ATN-1	10421-106C7	3.20	13.47	9.74
alveolar cell carcinoma cell line:SW 1573	10708-109H6	58.24	78.96	15.01
amniotic membrane cells, donor1	12235-129G3	41.04	54.48	77.44
amniotic membrane cells, donor2	12236-129G4	14.88	41.92	38.21
amniotic membrane cells, donor3	12237-129G5	30.64	50.97	102.52
amygdala - adult, donor10196	10167-103B5	7.11	9.49	43.87
amygdala, adult, donor10252	10151-102I7	9.73	17.24	40.35
amygdala, newborn, donor10223	10360-105E9	10.01	7.42	23.24
anaplastic carcinoma cell line:8305C	10428-106D5	42.27	39.47	13.62
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	23.39	37.73	16.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	4.01	28.06	23.05
aorta, adult, pool1	10052-101G7	31.38	33.93	50.60
appendix, adult	10189-103D9	26.39	27.17	42.69
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.85	42.99	4.82
artery, adult	10190-103E1	27.17	25.82	23.10
astrocytoma cell line:TM-31	10425-106D2	15.65	25.06	20.86
b cell line:RPMI1788	10427-106D4	24.54	38.51	16.95
basal cell carcinoma cell line:TE 354.T	10702-109G9	54.10	41.06	14.15
bile duct carcinoma cell line:HuCCT1	10432-106D9	17.56	34.63	10.72
bile duct carcinoma cell line:TFK-1	10496-107C1	23.27	17.74	24.60
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	1.12	8.39	10.63
bladder, adult, pool1	10011-101C2	16.19	15.21	39.76
blood, adult, pool1	10053-101G8	26.58	19.93	44.29
bone marrow stromal cell line:StromaNKtert	10686-109F2	47.96	35.97	12.85
bone marrow, adult	10192-103E3	29.69	24.29	18.22
brain, adult, donor1	10084-102B3	18.45	13.33	27.68
brain, adult, pool1	10012-101C3	5.23	11.14	20.38
brain, fetal, pool1	10085-102B4	10.69	16.03	56.10
breast carcinoma cell line:MCF7	10482-107A5	26.10	37.00	24.12
breast carcinoma cell line:MDA-MB-453	10419-106C5	195.97	143.55	23.84
breast, adult, donor1	10080-102A8	54.30	45.46	20.83
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	7.62	18.17	17.40
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	15.46	46.38	6.80
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	20.26	46.50	10.82
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	40.43	44.79	26.15
carcinoid cell line:NCI-H1770	10703-109H1	10.81	19.75	8.46
carcinoid cell line:NCI-H727	10735-110B6	78.10	63.77	37.30
carcinoid cell line:SK-PN-DW	10719-109I8	2.85	9.19	18.06
carcinosarcoma cell line:JHUCS-1	10642-109A3	5.06	15.70	13.84
caudate nucleus - adult, donor10196	10177-103C6	11.51	10.36	32.24
caudate nucleus, adult, donor10252	10164-103B2	6.02	10.71	44.01
caudate nucleus, adult, donor10258	10379-105H1	6.88	3.06	33.62
caudate nucleus, newborn, donor10223	10354-105E3	12.82	3.66	19.78
cerebellum - adult, donor10196	10173-103C2	11.65	23.31	93.22
cerebellum, adult, donor10252	10166-103B4	34.38	38.43	89.67
cerebellum, adult, pool1	10083-102B2	19.66	27.94	35.53
cerebellum, newborn, donor10223	10357-105E6	19.93	13.28	35.70
cerebral meninges, adult	10188-103D8	8.32	8.57	23.45
cerebrospinal fluid, donor2	10294-104G6	11.69	16.08	10.23
cervical cancer cell line:D98-AH2	10552-107I3	49.03	63.12	55.50
cervical cancer cell line:ME-180	10553-107I4	10.77	15.74	48.89
cervix, adult, pool1	10013-101C4	25.51	26.67	49.24
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	15.33	23.69	19.37
chondrosarcoma cell line:SW 1353	10700-109G7	19.59	24.82	9.14
choriocarcinoma cell line:BeWo	10423-106C9	7.58	24.48	13.30
choriocarcinoma cell line:SCH	10785-110H2	12.81	25.63	7.15
choriocarcinoma cell line:T3M-3	10618-108G6	1.90	13.99	9.49
chorionic membrane cells, donor1	12238-129G6	52.14	71.23	26.78
chorionic membrane cells, donor2	12239-129G7	60.45	51.60	10.74
chorionic membrane cells, donor3	12240-129G8	37.36	52.75	15.94
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	19.19	48.47
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	5.38	16.71	4.80
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	6.76	16.26	7.81
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	4.37	17.98	6.93
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	4.35	15.72	7.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	3.87	15.88	3.66
chronic myelogenous leukemia cell line:K562	10454-106G4	10.31	24.73	6.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	14.86	26.58	9.12
clear cell carcinoma cell line:JHOC-5	10638-108I8	7.54	33.14	10.97
clear cell carcinoma cell line:TEN	10636-108I6	18.39	41.29	25.51
colon carcinoma cell line:CACO-2	10513-107D9	40.09	58.02	20.13
colon carcinoma cell line:COLO-320	10420-106C6	8.74	50.55	5.70
colon, adult, donor1	10082-102B1	38.08	57.12	42.84
colon, adult, pool1	10014-101C5	28.67	29.61	37.60
colon, fetal, donor1	10070-101I7	23.48	24.10	45.11
common myeloid progenitor CMP, donor1	12130-128D6	27.50	68.75	229.18
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	19.12	8.92	10.20
cord blood derived cell line:COBL-a 24h infection	10453-106G3	20.53	19.47	9.96
cord blood derived cell line:COBL-a untreated	10449-106F8	23.13	22.42	12.55
corpus callosum, adult, pool1	10042-101F6	18.69	22.78	20.90
cruciate ligament, donor2	10295-104G7	35.66	40.52	34.85
diaphragm, fetal, donor1	10069-101I6	11.24	26.48	24.88
diencephalon, adult	10193-103E4	4.32	10.32	23.04
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	17.68	25.72	11.25
ductal cell carcinoma cell line:KLM-1	10438-106E6	17.44	28.98	28.72
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	14.68	20.94	4.81
ductus deferens, adult	10196-103E7	58.31	40.86	37.38
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	40.33	64.81
duodenum, fetal, donor1, tech_rep2	10071-101I8	23.54	29.43	83.13
dura mater, adult, donor1	10041-101F5	38.40	30.56	37.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	3.33	5.55	7.77
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	10.32	13.76	6.59
embryonic pancreas cell line:1B2C6	10604-108F1	16.65	25.90	6.17
embryonic pancreas cell line:1C3D3	10605-108F2	11.20	39.66	11.81
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.98	33.34	12.97
embryonic pancreas cell line:2C6	10603-108E9	13.13	51.23	17.08
endometrial carcinoma cell line:OMC-2	10497-107C2	33.18	46.59	12.07
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	5.44	19.21	15.41
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.01	15.92	10.29
epidermoid carcinoma cell line:A431	10426-106D3	10.00	14.78	19.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	8.47	22.22	5.28
epididymis, adult	10197-103E8	16.12	19.88	47.93
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	25.01	31.22	16.32
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	32.64	30.28	7.86
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	22.28	36.69	11.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	22.05	31.99	13.09
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	25.21	41.45	17.70
esophagus, adult, pool1	10015-101C6	12.74	17.41	43.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	15.90	26.05	6.76
eye - muscle inferior rectus, donor1	10272-104E2	9.66	19.32	31.39
eye - muscle lateral, donor2	10298-104H1	18.94	14.73	6.31
eye - muscle medial, donor2	10299-104H2	19.35	16.37	25.30
eye - muscle superior, donor2	10297-104G9	17.20	21.78	21.78
eye - vitreous humor, donor1	10268-104D7	27.69	26.23	27.69
eye, fetal, donor1	10054-101G9	16.53	16.53	52.37
fibrosarcoma cell line:HT-1080	10758-110E2	43.60	49.37	8.98
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	29.20	62.44	18.04
frontal lobe, adult, pool1	10040-101F4	5.54	13.42	33.12
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	11.71	22.52	23.42
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	15.45	44.71	37.21
gall bladder, adult	10198-103E9	34.77	32.83	40.80
gamma delta positive T cells, donor1	11937-126A2	3.76	11.27	44.56
gamma delta positive T cells, donor2	11938-126A3	7.10	8.59	54.53
gastric adenocarcinoma cell line:MKN1	10614-108G2	36.12	46.68	14.36
gastric adenocarcinoma cell line:MKN45	10612-108F9	10.64	29.01	27.08
gastric cancer cell line:AZ521	10549-107H9	5.08	20.66	7.05
gastric cancer cell line:GSS	10560-108A2	1.83	19.22	40.27
gastrointestinal carcinoma cell line:ECC12	10615-108G3	10.74	26.50	8.22
giant cell carcinoma cell line:LU65	10487-107B1	31.44	16.87	11.47
giant cell carcinoma cell line:Lu99B	10433-106E1	28.27	52.62	10.50
glassy cell carcinoma cell line:HOKUG	10688-109F4	44.65	42.65	48.89
glioblastoma cell line:A172, tech_rep1	10444-106F3	20.90	29.55	12.88
glioblastoma cell line:A172, tech_rep2	10444-106F3	21.21	34.41	14.47
glioblastoma cell line:T98G	10485-107A8	33.99	63.24	8.83
glioma cell line:GI-1	10413-106B8	44.81	47.15	13.77
globus pallidus - adult, donor10196	10175-103C4	12.39	12.39	19.68
globus pallidus, adult, donor10252	10161-103A8	20.26	23.92	26.12
globus pallidus, adult, donor10258	10367-105F7	5.48	9.58	13.69
globus pallidus, newborn, donor10223	10364-105F4	5.86	4.80	13.86
granulocyte macrophage progenitor, donor1	12131-128D7	44.05	80.76	132.15
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	32.79	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	31.36	26.13
granulosa cell tumor cell line:KGN	10624-108H3	107.84	58.88	19.84
hIPS +CCl2, biol_rep1	14383-156B9	13.77	37.65	9.64
hIPS +CCl2, biol_rep2	14384-156C1	8.69	35.21	11.43
hIPS +CCl2, biol_rep3	14385-156C2	6.44	38.65	19.32
hIPS, biol_rep1	14380-156B6	2.87	37.37	10.06
hIPS, biol_rep2	14381-156B7	10.97	48.70	11.66
hIPS, biol_rep3	14382-156B8	8.83	16.55	16.55
hairy cell leukemia cell line:Mo	10712-109I1	25.00	33.91	17.24
heart - mitral valve, adult	10205-103F7	22.42	15.25	34.98
heart - pulmonic valve, adult	10206-103F8	17.52	12.81	44.71
heart - tricuspid valve, adult	10207-103F9	28.31	18.32	26.64
heart, adult, diseased post-infarction, donor1	10050-101G5	8.98	16.32	48.77
heart, adult, diseased, donor1	10051-101G6	7.24	17.46	68.98
heart, adult, pool1	10016-101C7	10.12	14.49	46.00
heart, fetal, pool1	10046-101G1	9.04	13.76	75.68
hepatic mesenchymal tumor cell line:LI90	10778-110G4	52.76	51.52	18.51
hepatoblastoma cell line:HuH-6	10633-108I3	11.89	16.65	32.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	39.45	53.81	11.71
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	38.23	53.53	14.08
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	43.35	53.05	16.88
hepatoma cell line:Li-7	10484-107A7	99.65	46.71	12.68
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	35.98	42.41	10.95
hippocampus - adult, donor10196	10169-103B7	5.68	17.03	41.64
hippocampus, adult, donor10252	10153-102I9	14.08	21.02	41.43
hippocampus, adult, donor10258	10374-105G5	2.49	6.47	28.88
hippocampus, newborn, donor10223	10363-105F3	9.87	4.93	29.26
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	5.49	15.87	9.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	8.64	20.62	12.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	8.89	16.50	10.41
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	4.51	22.55	14.66
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	5.94	20.92	18.85
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	5.69	19.74	20.12
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	7.30	20.14	24.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	7.32	30.16	29.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	6.26	27.53	17.52
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	11.60	25.10	17.05
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	17.20	35.36	24.11
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	8.75	22.22	20.87
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	9.23	17.84	9.86
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	5.90	18.18	6.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	8.73	8.73	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	5.35	23.86	12.60
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	8.29	26.16	20.50
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	4.00	15.49	11.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	5.09	14.32	24.30
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	4.55	21.37	24.55
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	5.01	16.91	23.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	16.33	29.56	23.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.35	24.10	21.77
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.96	26.90	23.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	10.35	18.84	16.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	10.84	20.54	21.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	8.57	16.74	13.47
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.86	25.70	23.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	9.19	18.05	18.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	6.66	17.85	19.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	5.17	19.65	27.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.30	14.61	31.88
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	9.49	15.65	25.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	15.08	28.89	32.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	7.57	24.23	37.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	17.47	22.52	24.87
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	12.32	26.08	20.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	8.91	19.16	19.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	10.24	14.63	19.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	3.97	22.62	31.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	6.51	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	4.30	8.60	17.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	4.38	18.61	37.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	4.34	14.84	25.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	3.91	13.52	23.13
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	20.29	25.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	14.08	29.79	29.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	8.89	22.63	17.24
immature langerhans cells, donor1	11904-125F5	7.99	11.38	10.65
immature langerhans cells, donor2	11905-125F6	1.58	4.75	18.22
insula, adult, pool1	10039-101F3	7.85	16.37	40.79
keratoacanthoma cell line:HKA-1	10791-110H8	3.25	15.28	15.28
kidney, adult, pool1	10017-101C8	62.98	39.15	31.14
kidney, fetal, pool1	10045-101F9	15.00	23.98	67.91
large cell lung carcinoma cell line:IA-LM	10509-107D5	32.10	55.96	18.75
large cell lung carcinoma cell line:NCI-H460	10839-111E2	67.60	38.29	14.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	11.19	23.49	12.29
left atrium, adult, donor1	10079-102A7	10.35	19.07	26.70
left ventricle, adult, donor1	10078-102A6	8.60	11.63	35.90
leiomyoblastoma cell line:G-402	10721-110A1	19.15	31.19	6.57
leiomyoma cell line:10964C	10569-108B2	91.25	63.23	30.90
leiomyoma cell line:15242A	10570-108B3	128.26	53.80	26.09
leiomyoma cell line:15425	10571-108B4	90.33	54.63	29.87
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	25.40	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	16.73	24.05	6.27
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	9.21	24.91	10.74
liposarcoma cell line:KMLS-1	10782-110G8	99.97	84.20	24.21
liposarcoma cell line:SW 872	10726-110A6	18.40	38.87	4.39
liver, adult, pool1	10018-101C9	257.03	48.29	29.33
liver, fetal, pool1	10086-102B5	35.75	26.34	26.34
locus coeruleus - adult, donor10196	10182-103D2	13.71	13.27	18.37
locus coeruleus, adult, donor10252	10165-103B3	12.55	21.22	23.44
locus coeruleus, adult, donor10258	10375-105G6	5.08	10.16	11.29
locus coeruleus, newborn, donor10223	10362-105F2	14.72	9.25	13.04
lung adenocarcinoma cell line:A549	10499-107C4	51.62	36.26	15.92
lung adenocarcinoma cell line:PC-14	10408-106B3	17.92	46.19	18.61
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	8.44	32.56	11.73
lung, adult, pool1	10019-101D1	50.68	32.60	37.56
lung, fetal, donor1	10068-101I5	10.85	18.27	109.60
lung, right lower lobe, adult, donor1	10075-102A3	31.62	32.53	32.08
lymph node, adult, donor1	10077-102A5	27.46	25.09	29.82
lymphangiectasia cell line:DS-1	10727-110A7	12.49	22.79	9.86
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	20.68	29.13	40.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	7.65	12.74	28.03
mature adipocyte, donor1	12231-129F8	8.88	26.20	29.75
mature adipocyte, donor2	12232-129F9	14.11	23.87	26.98
mature adipocyte, donor3	12233-129G1	14.70	25.60	29.40
mature adipocyte, donor4	12234-129G2	17.64	16.58	25.80
maxillary sinus tumor cell line:HSQ-89	10414-106B9	4.29	18.58	24.30
medial frontal gyrus - adult, donor10196	10170-103B8	9.02	12.41	30.46
medial frontal gyrus, adult, donor10252	10150-102I6	9.38	15.08	38.25
medial frontal gyrus, adult, donor10258	10368-105F8	3.81	7.94	24.78
medial frontal gyrus, newborn, donor10223	10352-105E1	5.54	6.40	15.35
medial temporal gyrus - adult, donor10196	10183-103D3	8.78	7.26	31.22
medial temporal gyrus, adult, donor10252	10156-103A3	11.04	15.28	39.26
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	1.93	30.82
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	43.06
medial temporal gyrus, newborn, donor10223	10353-105E2	8.26	8.97	36.25
medulla oblongata - adult, donor10196	10174-103C3	12.98	13.63	24.66
medulla oblongata, adult, donor10252	10155-103A2	19.04	25.08	28.79
medulla oblongata, adult, pool1	10038-101F2	21.22	22.86	26.04
medulla oblongata, newborn, donor10223	10361-105F1	12.85	6.94	17.01
medulloblastoma cell line:D283 Med	10838-111E1	11.73	26.79	9.52
medulloblastoma cell line:ONS-76	10759-110E3	15.65	26.29	11.49
melanoma cell line:COLO 679	10514-107E1	9.92	16.96	5.75
melanoma cell line:G-361	10465-106H6	20.63	34.20	12.22
meningioma cell line:HKBMM	10691-109F7	123.74	54.09	8.68
merkel cell carcinoma cell line:MKL-1	10843-111E6	1.76	16.74	12.34
merkel cell carcinoma cell line:MS-1	10844-111E7	0.78	5.44	8.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	49.87	49.87	21.17
mesenchymal precursor cell - adipose, donor2	11748-123G2	19.81	24.72	12.54
mesenchymal precursor cell - adipose, donor3	11749-123G3	55.49	53.42	29.82
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	45.09	46.64	16.86
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	44.87	37.94	22.53
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	88.15	51.36	29.15
mesenchymal precursor cell - cardiac, donor1	11752-123G6	55.78	35.01	11.50
mesenchymal precursor cell - cardiac, donor2	11753-123G7	41.87	35.31	21.62
mesenchymal precursor cell - cardiac, donor3	11754-123G8	45.36	43.90	16.58
mesenchymal precursor cell - cardiac, donor4	11755-123G9	49.02	37.95	18.64
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	65.58	53.35	17.93
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	36.89	23.71	9.22
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	42.48	45.25	19.51
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	74.01	57.60	22.69
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	36.55	43.28	21.23
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	43.85	25.52	17.25
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	41.59	43.04	15.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	92.79	42.63	19.61
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	50.77	35.24	23.50
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	26.00	30.93	13.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	47.97	40.53	9.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	57.06	44.18	18.04
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	66.10	37.77	16.31
mesenchymal stem cell line:Hu5/E18	10568-108B1	54.73	39.15	12.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	25.12	27.40	9.13
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	27.88	28.14	11.25
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	31.15	30.89	12.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	24.03	27.11	12.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	25.18	26.12	11.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	30.46	31.14	12.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	22.40	28.69	14.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	25.49	19.00	9.27
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	34.03	35.76	16.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.76	26.55	12.49
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	33.41	25.48	13.94
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.80	27.87	15.40
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	25.85	26.18	9.06
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	31.93	22.93	13.10
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	29.21	22.77	14.18
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	30.08	13.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	25.82	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	25.66	24.36	10.07
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	18.91	10.18
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	30.39	25.59	11.19
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	23.72	9.81
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.99	28.77	14.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	20.99	10.49
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	22.85	22.85	10.93
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	24.31	17.20	13.64
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	13.40	31.68	12.18
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.97	25.34	12.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	36.56	25.52	11.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	27.94	17.19
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	31.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	58.55	27.55	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	59.08	27.71	12.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	48.46	35.75	7.15
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	55.42	22.99	14.15
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	47.38	26.49	9.66
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	38.76	24.06	9.36
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	41.39	27.20	15.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	38.52	15.41
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	41.99	26.16	9.64
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	39.58	30.68	17.81
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	33.65	19.07	13.46
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	38.16	22.90	14.63
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	57.63	29.82	17.73
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	65.42	34.89	17.44
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	57.02	30.41	16.47
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	32.17	21.85	14.57
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	36.15	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	30.48	22.24	14.83
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	38.69	24.80	16.07
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	44.78	27.26	14.28
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	50.93	32.60	28.52
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.85	18.57	15.47
mesothelioma cell line:ACC-MESO-1	10493-107B7	81.98	104.65	24.81
mesothelioma cell line:ACC-MESO-4	10494-107B8	23.86	21.08	16.91
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	34.19	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	40.69	23.02	8.43
mesothelioma cell line:Mero-25	10850-111F4	29.50	15.66	8.17
mesothelioma cell line:Mero-41	10851-111F5	47.67	51.34	15.65
mesothelioma cell line:Mero-48a	10852-111F6	32.33	55.14	19.93
mesothelioma cell line:Mero-82	10853-111F7	48.88	40.73	12.35
mesothelioma cell line:Mero-83	10854-111F8	28.77	21.11	7.32
mesothelioma cell line:Mero-84	10855-111F9	69.51	39.69	20.98
mesothelioma cell line:Mero-95	10856-111G1	54.45	44.31	17.81
mesothelioma cell line:NCI-H2052	10847-111F1	90.11	59.14	13.75
mesothelioma cell line:NCI-H226	10846-111E9	57.01	29.14	11.40
mesothelioma cell line:NCI-H2452	10848-111F2	42.53	44.07	7.52
mesothelioma cell line:NCI-H28	10845-111E8	27.99	34.10	18.58
mesothelioma cell line:No36	10857-111G2	20.88	19.25	5.22
mesothelioma cell line:ONE58	10858-111G3	43.62	24.66	4.61
migratory langerhans cells, donor1	11901-125F2	18.62	20.34	5.18
migratory langerhans cells, donor2	11902-125F3	24.42	30.41	16.61
migratory langerhans cells, donor3	11903-125F4	25.67	33.02	15.79
mixed mullerian tumor cell line:HTMMT	10689-109F5	43.10	38.85	11.75
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	62.31	55.74	13.14
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	66.57	74.41	42.16
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	6.66	14.27	20.93
myelodysplastic syndrome cell line:SKM-1	10772-110F7	5.73	17.00	18.29
myeloma cell line:PCM6	10474-106I6	69.58	73.93	20.95
myxofibrosarcoma cell line:MFH-ino	10600-108E6	8.62	24.35	5.58
myxofibrosarcoma cell line:NMFH-1	10684-109E9	36.68	44.92	8.43
nasal epithelial cells, donor1, tech_rep1	12226-129F3	10.14	15.15	21.84
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.82	12.06	21.33
nasal epithelial cells, donor2	12227-129F4	17.11	75.07	24.29
neuroblastoma cell line:CHP-134	10508-107D4	8.51	25.54	25.54
neuroblastoma cell line:NB-1	10539-107G8	15.53	31.43	19.83
neuroblastoma cell line:NBsusSR	10607-108F4	5.69	32.06	27.42
neuroblastoma cell line:NH-12	10555-107I6	19.94	42.49	34.85
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	1.19	5.46	26.57
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	2.69	12.20	29.30
neuroectodermal tumor cell line:TASK1	10774-110F9	5.64	19.32	11.07
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.64	3.81	52.77
neurofibroma cell line:Hs 53.T	10729-110A9	50.57	54.30	14.64
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	500.26	167.43	51.41
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	10.41	10.41	6.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	32.70	33.02	34.95
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	25.75	14.45	9.99
nucleus accumbens, adult, pool1	10037-101F1	8.91	13.12	39.09
occipital cortex - adult, donor10196	10172-103C1	0.00	8.24	39.15
occipital cortex, adult, donor10252	10163-103B1	15.83	18.25	49.11
occipital cortex, newborn, donor10223	10355-105E4	13.47	10.19	47.68
occipital lobe, adult, donor1	10076-102A4	4.20	9.97	27.29
occipital lobe, fetal, donor1	10073-102A1	2.57	25.75	45.91
occipital pole, adult, pool1	10036-101E9	7.33	11.43	41.16
olfactory region, adult	10195-103E6	3.82	10.51	28.08
optic nerve, donor1	10277-104E7	14.01	26.01	22.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	11.96	25.52	14.58
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	7.14	23.77	5.36
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	1.52	6.77	14.39
oral squamous cell carcinoma cell line:SAS	10544-107H4	26.10	49.78	17.79
osteoclastoma cell line:Hs 706.T	10704-109H2	29.69	28.81	14.40
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	45.78	56.06	28.03
osteosarcoma cell line:HS-Os-1	10558-107I9	20.57	25.87	9.97
ovary, adult, pool1	10020-101D2	11.27	19.13	44.20
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	21.82	25.85	11.37
pancreas, adult, donor1	10049-101G4	40.45	57.38	82.78
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1.96	6.15	2.24
papillary adenocarcinoma cell line:8505C	10437-106E5	112.43	60.13	17.72
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	12.75	18.38	11.43
paracentral gyrus, adult, pool1	10035-101E8	7.32	12.72	33.95
parietal cortex, adult, donor10258	10373-105G4	7.34	33.03	28.63
parietal lobe - adult, donor10196	10171-103B9	6.58	12.23	31.04
parietal lobe, adult, donor10252	10157-103A4	6.84	10.83	37.62
parietal lobe, adult, pool1	10034-101E7	7.58	14.19	31.63
parietal lobe, fetal, donor1	10072-101I9	3.88	14.55	35.88
parietal lobe, newborn, donor10223	10356-105E5	11.22	11.59	34.77
parotid gland, adult	10199-103F1	22.20	43.78	85.72
penis, adult	10200-103F2	18.80	18.80	50.49
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.74	1.30	13.76
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.95	29.28	18.36
pineal gland - adult, donor10196	10179-103C8	7.74	14.19	58.70
pineal gland, adult, donor10252	10160-103A7	8.88	22.50	53.89
pineal gland, adult, donor10258	10377-105G8	3.14	4.39	33.86
pituitary gland - adult, donor10196	10180-103C9	16.19	28.33	55.65
pituitary gland, adult, donor10252	10162-103A9	16.16	35.44	69.84
pituitary gland, adult, donor10258	10378-105G9	16.17	18.73	26.39
placenta, adult, pool1	10021-101D3	34.72	23.01	26.02
plasma cell leukemia cell line:ARH-77	10840-111E3	12.18	18.67	16.29
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	27.24	39.53	24.90
pons, adult, pool1	10033-101E6	11.53	15.49	22.55
postcentral gyrus, adult, pool1	10032-101E5	7.24	11.42	38.10
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	18.82	43.92
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	23.47	11.74
prostate cancer cell line:DU145	10490-107B4	38.89	53.17	9.91
prostate cancer cell line:PC-3	10439-106E7	41.75	74.60	10.16
prostate, adult, pool1	10022-101D4	33.83	30.11	44.80
putamen, adult, donor10196	10176-103C5	8.03	11.57	45.32
putamen, adult, donor10252	10152-102I8	5.88	5.88	27.45
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	6.56	20.76
putamen, adult, donor10258, tech_rep2	10372-105G3	3.87	5.32	30.68
putamen, newborn, donor10223	10365-105F5	11.99	5.25	8.25
rectal cancer cell line:TT1TKB	10469-106I1	17.17	35.49	13.09
rectum, fetal, donor1	10067-101I4	5.56	15.30	116.84
renal cell carcinoma cell line:OS-RC-2	10411-106B6	76.74	62.75	51.30
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	26.10	36.45	47.22
retina, adult, pool1	10030-101E3	13.22	17.79	57.35
retinoblastoma cell line:Y79	10475-106I7	7.53	23.38	7.27
rhabdomyosarcoma cell line:KYM-1	10787-110H4	36.02	35.53	10.82
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	15.47	34.59	11.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	20.46	21.98	14.40
salivary acinar cells, donor1	11771-123I7	41.44	33.67	21.04
salivary acinar cells, donor2	11772-123I8	27.12	30.57	38.41
salivary acinar cells, donor3	11773-123I9	9.93	21.19	56.27
salivary gland, adult, pool1	10093-102C3	30.31	61.77	141.27
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	25.97	29.17	8.35
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	22.92	33.03	8.58
seminal vesicle, adult	10201-103F3	42.33	33.33	36.51
serous adenocarcinoma cell line:JHOS-2	10639-108I9	13.36	18.71	27.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	30.20	34.22	13.08
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	34.12	34.12	18.06
serous cystadenocarcinoma cell line:HTOA	10693-109F9	143.45	62.19	28.88
signet ring carcinoma cell line:Kato III	10436-106E4	8.95	19.01	14.04
signet ring carcinoma cell line:NUGC-4	10483-107A6	27.74	29.55	13.68
skeletal muscle - soleus muscle, donor1	10282-104F3	16.31	14.19	11.35
skeletal muscle, adult, pool1	10023-101D5	24.59	21.23	14.03
skeletal muscle, fetal, donor1	10066-101I3	6.03	21.11	43.22
skin, adult, donor1	10074-102A2	6.79	13.57	54.28
skin, fetal, donor1	10065-101I2	7.57	17.04	68.80
small cell cervical cancer cell line:HCSC-1	10800-110I8	20.34	44.03	9.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	6.93	21.43	10.09
small cell lung carcinoma cell line:DMS 144	10841-111E4	3.66	30.26	15.61
small cell lung carcinoma cell line:LK-2	10541-107H1	14.50	34.78	16.81
small cell lung carcinoma cell line:NCI-H82	10842-111E5	3.86	25.41	7.08
small cell lung carcinoma cell line:WA-hT	10562-108A4	16.56	42.28	23.32
small intestine, adult, pool1	10024-101D6	41.09	38.46	67.01
small intestine, fetal, donor1	10064-101I1	7.37	14.25	61.18
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	114.89	49.24	30.26
smooth muscle, adult, pool1	10048-101G3	10.08	19.64	38.51
somatostatinoma cell line:QGP-1	10781-110G7	44.76	67.27	73.17
spinal cord - adult, donor10196	10181-103D1	20.65	18.35	16.29
spinal cord, adult, donor10252	10159-103A6	15.77	18.53	18.14
spinal cord, adult, donor10258	10369-105F9	8.99	2.77	19.37
spinal cord, fetal, donor1	10056-101H2	9.15	18.90	45.74
spinal cord, newborn, donor10223	10359-105E8	10.56	11.94	15.15
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	79.16	48.54	23.60
spleen, adult, pool1	10025-101D7	43.17	31.72	31.17
spleen, fetal, pool1	10044-101F8	41.24	31.70	46.80
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	16.98	23.29	5.80
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	2.28	15.38	16.90
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	3.84	19.92	25.51
squamous cell carcinoma cell line:T3M-5	10616-108G4	26.58	24.63	23.46
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	6.42	17.00	17.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	3.39	10.59	11.86
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	33.85	44.42	11.00
stomach, fetal, donor1	10062-101H8	43.79	42.72	88.64
submaxillary gland, adult	10202-103F4	23.93	24.50	69.50
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	21.19	20.98	23.26
substantia nigra, adult, donor10258	10371-105G2	4.66	10.86	17.07
substantia nigra, newborn, donor10223	10358-105E7	14.13	9.89	15.54
synovial sarcoma cell line:HS-SY-II	10441-106E9	2.52	12.61	12.38
temporal lobe, adult, pool1	10031-101E4	9.16	16.11	36.45
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	4.99	27.07	70.51
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	6.59	22.42	44.83
tenocyte, donor1	11763-123H8	52.02	53.41	25.14
tenocyte, donor2	11765-123I1	48.83	40.06	17.17
tenocyte, donor3	11768-123I4	75.62	47.82	34.10
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	20.23	45.38	14.62
teratocarcinoma cell line:NCR-G1	10798-110I6	11.87	23.12	6.94
teratocarcinoma cell line:PA-1	10807-111A6	7.44	19.06	16.27
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	21.83	37.83	6.86
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	7.56	21.56	16.64
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	6.33	13.31	5.02
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	4.23	8.79	11.07
testis, adult, pool1	10026-101D8	30.49	23.84	26.63
testis, adult, pool2	10096-102C6	37.44	26.16	29.77
thalamus - adult, donor10196	10168-103B6	15.46	18.77	18.77
thalamus, adult, donor10252	10154-103A1	16.88	22.97	23.44
thalamus, adult, donor10258, tech_rep1	10370-105G1	9.24	4.62	24.63
thalamus, adult, donor10258, tech_rep2	10370-105G1	6.75	10.70	14.82
thalamus, newborn, donor10223	10366-105F6	10.36	12.08	18.41
throat, adult	10209-103G2	18.48	20.47	34.95
throat, fetal, donor1	10061-101H7	9.75	14.02	68.25
thymic carcinoma cell line:Ty-82	10803-111A2	3.78	18.08	33.98
thymus, adult, pool1	10027-101D9	7.85	12.03	92.16
thymus, fetal, pool1	10043-101F7	25.98	27.53	108.37
thyroid carcinoma cell line:KHM-5M	10776-110G2	48.40	33.51	15.29
thyroid carcinoma cell line:TCO-1	10783-110G9	89.82	86.19	23.47
thyroid, adult, pool1	10028-101E1	27.43	28.65	112.63
thyroid, fetal, donor1	10060-101H6	13.45	19.51	87.80
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	43.11	70.83
tongue, adult	10203-103F5	21.86	18.14	25.82
tongue, fetal, donor1	10059-101H5	12.22	20.89	39.80
tonsil, adult, pool1	10047-101G2	27.15	36.56	49.39
trachea, adult, pool1	10029-101E2	45.07	33.05	46.22
trachea, fetal, donor1	10058-101H4	23.85	30.78	80.02
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	75.11	53.50	19.13
transitional-cell carcinoma cell line:5637	10418-106C4	16.92	37.79	12.26
transitional-cell carcinoma cell line:JMSU1	10492-107B6	25.85	49.20	8.77
tridermal teratoma cell line:HGRT	10694-109G1	20.93	24.73	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	7.79	26.16	7.20
umbilical cord, fetal, donor1	10057-101H3	4.17	12.52	35.47
uterus, adult, pool1	10100-102D1	17.75	27.98	59.38
uterus, fetal, donor1	10055-101H1	11.26	13.82	74.23
vagina, adult	10204-103F6	62.68	20.03	61.39
vein, adult	10191-103E2	18.85	18.19	36.17
xeroderma pigentosum b cell line:XPL 17	10563-108A5	18.16	32.58	16.56